Skip to main content
Equibles

BARCLAYS PLC

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 312069 LONDON, X0
Back to KPTI Full portfolio

Position in KPTI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,620,881
+$1,579,530 QoQ
Shares Held
165,904
+2134.7% QoQ
Ownership
0.731%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 96 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. KPTI ranks #91 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in KPTI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,620,881 165,904
2026-03-31 $41,351 7,424
2025-12-31 $30,242 4,109
2025-09-30 $26,872 4,109
2025-06-30 $22,985 5,333
2025-03-31 $19,945 5,333
2024-12-31 $64,633 95,611
2024-09-30 $79,486 95,767
2024-06-30 $758,001 873,274
2024-03-31 $1,348,150 892,815
2023-12-31 $839,103 970,062
2023-09-30 $1,544,079 1,152,298
2023-06-30 $1,980,385 1,106,361
2023-03-31 $11,076,343 2,847,389
2022-12-31 $3,558,820 1,046,712
2022-09-30 $2,486,833 455,464
2022-06-30 $369,481 81,925
2022-03-31 $646,525 87,724
2021-12-31 $1,168,665 181,752
2021-09-30 $770,503 132,389
2021-06-30 $2,051,357 198,775
2021-03-31 $2,886,413 274,374
2020-12-31 $3,567,597 230,465
2020-09-30 $780,982 53,492
2020-06-30 $1,363,963 72,015
2020-03-31 $1,151,389 59,937